Vn. Kristensen et al., CYP17 and breast cancer risk: The polymorphism in the 5 ' flanking area ofthe gene does not influence binding to Sp-1, CANCER RES, 59(12), 1999, pp. 2825-2828
The ability of a motif of the CYP17 5' untranslated region, created by a po
lymorphic T to C substitution, to bind to the human transcription factor Sp
-1 was investigated. No binding of any of the polymorphic alleles was obser
ved in electromobility shift assay. No other sequence within +1 to +100 of
each of the CYP17 alleles formed complex with the Sp-l or enhanced binding
to the polymorphic CACC box. Genotyping of 510 breast cancer patients and 2
01 controls revealed no difference in genotype frequencies. Age at onset, t
umor grade, lymph node status and distant metastases, stage, and estrogen a
nd progesterone receptor status were not associated with the CYP17 genotype
.